HEALTH, BIOTECHNOLOGY & PHARMACEUTICALS - MARKET SECTORS

The concept of a recession-proofed sector is, arguably, a dated perception, particularly when considering the high costs of product research, development, approval and general compliance.

Costs at all levels are under scrutiny, including those for design, engineering and plant construction. It is increasingly recognised that present day levels of investment and inherent need for flexibility demand appropriately sized and 'fit for purpose' supply organisations, working in partnership.

In such a difficult market place, combined with the need to sustain competitive advantage and accelerate new products to market, PROjEN has the people and product mix to add value to its clients' engineering functions.

The consolidation and growth of PROjEN's pharmaceutical business is a reflection of this evolution. Alliance agreements with leading companies such as Aventis Pharma and AstraZeneca are complemented with approved supplier status for other blue chips including clients such as GlaxoSmithKline.

In recent years, PROjEN have completed a number of both large and smaller projects in the following specialist market places:-

1. Primary pharmaceuticals and active ingredients
2. Secondary pharmaceuticals
3. Biotechnology
4. Personal care
5. Nutrition
6. Related infrastructure works
7. Laboratories, development rigs, pilot scale facilities and multi purpose plants

With experience in:-

1. Solids/powder handling and processing
2. Liquid handling and processing
3. Contamination control and clean room specification / operation(flow logistics)
4. Toxic / bioactive materials handling, control and containment
5. ATEX / DSEAR directives
6. SHE, CDM, Hazop all with cGMP compliance.
7. Refrigeration technology